Real-world outcomes of chemotherapy plus immune checkpoint inhibitors versus chemotherapy alone in advanced, unresectable, and recurrent intrahepatic cholangiocarcinoma

BackgroundThere are limited treatment options available to improve the prognosis of patients with advanced or metastatic cholangiocarcinoma particularly intrahepatic cholangiocarcinoma (iCCA). This study aimed to evaluate the efficacy and safety of combining chemotherapy plus anti-PD-1/L1 drugs comp...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Tinotenda Blessing Madzikatire, Shan Heng, HongYi Gu, YunFeng Shan, EnHua Lin, Joshua Banda, Asta Debora, Brandon Anotida Madziva, Mutale Jaeste Bowa, Munyaradzi Godfrey Mudhuri, Canol Bwalya
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-05-01
Subjects:	advanced unresectable recurrent intrahepatic cholangiocarcinoma (iCCA) immunotherapy chemotherapy combination (combined) therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1390887/full